- BioSante Pharmaceuticals (NASDAQ:BPAX) on Thursday entered into an all-stock merger agreement with emerging generic drug manufacturer, ANI Pharmaceuticals, causing BPAX shares to swing between $1.89 … Continue Reading
Read nowLong Ideas - Endo Pharmaceuticals (NASDAQ:ENDP) is hosting its analyst day today in NY, and despite guiding for lower 2013 revenues and EPS compared to Wall Street Consensus … Continue Reading
Read nowLong Ideas - By David Moskowitz Sunesis Pharmaceuticals (NASDAQ:SNSS) has had a great year thus far, up 350% since January, and importantly, the smart money continues to flock … Continue Reading
Read nowLong Ideas - Major Drug and Diagnostics company, Roche Holdings (OTC:RHBBY) appears to be coming back to the table to take another run at acquiring Illumina (NASDAQ:ILMN), according … Continue Reading
Read nowLong Ideas - By now, the bear story on Questcor Pharmaceuticals (NASDAQ:QCOR) is well understood, with health insurer Aetna (NYSE:AET) indicating that it will make it next-to-impossible to … Continue Reading
Read nowLong Ideas - With Wall Street Analyst price targets on Ariad Pharmaceuticals (NASDAQ:ARIA) averaging $24.75 through this morning, new data for an early-stage pipeline candidate is causing price … Continue Reading
Read nowMost Popular - By David Moskowitz Peregrine Pharmaceuticals (NASDAQ:PPHM) opened down in early trading, as investors are still getting over the shock of the favorable clinical trial results … Continue Reading
Read now